Tonix Pharmaceuticals Holding (TNXP) Non Operating Income: 2023-2025
Historic Non Operating Income for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Sep 2025 value amounting to -$1.2 million.
- Tonix Pharmaceuticals Holding's Non Operating Income fell 2527.27% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.2 million, marking a year-over-year decrease of 240.13%. This contributed to the annual value of -$2.1 million for FY2024, which is 220.73% down from last year.
- According to the latest figures from Q3 2025, Tonix Pharmaceuticals Holding's Non Operating Income is -$1.2 million, which was up 40.87% from -$2.0 million recorded in Q2 2025.
- In the past 5 years, Tonix Pharmaceuticals Holding's Non Operating Income ranged from a high of $394,000 in Q1 2025 and a low of -$2.0 million during Q2 2025.
- In the last 3 years, Tonix Pharmaceuticals Holding's Non Operating Income had a median value of -$593,000 in 2024 and averaged -$585,333.
- Per our database at Business Quant, Tonix Pharmaceuticals Holding's Non Operating Income crashed by 21,342.86% in 2024 and then skyrocketed by 166.44% in 2025.
- Tonix Pharmaceuticals Holding's Non Operating Income (Quarterly) stood at $7,000 in 2023, then slumped by 21,342.86% to -$1.5 million in 2024, then slumped by 2,527.27% to -$1.2 million in 2025.
- Its Non Operating Income was -$1.2 million in Q3 2025, compared to -$2.0 million in Q2 2025 and $394,000 in Q1 2025.